Strategic partnership leverages AI and robotics for novel therapeutics across oncology, immunology, inflammation, neurology, and metabolic diseases.
XtalPi, a leading global technology company in integrating artificial intelligence (AI) and robotics for drug and materials discovery, announced a transformative strategic collaboration with DoveTree Medicines, a biotechnology pioneer founded by renowned drug...
Lane to lead product and engineering strategy, driving innovation and growth in AI-powered real-world evidence and outcomes solutions for healthcare
OM1, the leader in real-world evidence (RWE) generation and AI-driven insights for healthcare and life sciences, announced the appointment of Hunter Lane as Chief Product Officer. In this role, Lane...
Turbine, a leading developer of cell simulations with AI, announced a research collaboration with MSD (the tradename of Merck & Co., Inc., Rahway NJ USA) to create simulations of cancer patient populations that remain difficult to treat and study in laboratory settings.
To develop novel treatments for patients, scientists must...
BioDuro, a globally trusted Contract Research, Development, and Manufacturing Organization (CRDMO), and Atombeat Inc., a leading force in AI for drug discovery, announced a strategic collaboration to an AI powered platform for accelerated peptide drug discovery.
This collaboration brings together Atombeat’s in silico modeling expertise, AI-accelerated & data-driven design platform...
CAS, a division of the American Chemical Society specializing in scientific knowledge management, announces the release of the newest version of CAS SciFinder®, the leading scientific search and analysis platform. By integrating advanced AI, optimized for scientific applications, with the largest collection of global scientific knowledge, managed by people,...
Test Finder interprets provider questions in context to deliver curated, clinically relevant results, going beyond traditional search
Labcorp, a global leader of innovative and comprehensive laboratory services, announced the launch of Test Finder, a first-of-its-kind generative AI tool developed with Amazon Web Services (AWS). Designed to simplify lab test selection,...
Scopio's Complete Blood Morphology (CBM®) ushers in a new era of lab automation, analyzing 10x more cells than the current standard of care in blood cell morphology, addressing global laboratory staffing crisis and accelerating hematology workflows and efficiencies
Scopio Labs, developer of Full-Field Cell Morphology imaging and analysis platform, announced...
A Specialized Practice Environment to Sharpen Clinical Fluency, Master Product Messaging, and Drive Continuous Improvement Through a Gamified Experience
ACTO, a leader in AI-first commercial learning, enablement, and customer engagement solutions for life sciences and a Veeva Product Partner and member of the Veeva AI Partner Program, announced the launch...
Advanced NVIDIA GPU Integration Transforms Genome and Multiomics Alignment, Variant Calling and Reporting Capabilities
Dante Omics AI, a pioneering force in computational genomics, announced a groundbreaking upgrade to its proprietary genome and multiomics alignment, variant calling and reporting platform. The enhanced system leverages cutting-edge NVIDIA GPU technology to deliver unprecedented...
Lantern Pharma Inc., a clinical-stage oncology company leveraging its proprietary RADR® artificial intelligence (AI) platform to accelerate drug discovery, announced that the European Patent Office (EPO) has issued a notice of allowance for a composition of matter patent covering its drug candidate LP-284. This patent, expected to be granted in...
